Product Information

NAMZARIC 14 MG-10 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $19.8498 per EA under NDC 00456121430. Its NADAC has been published 557 times since Dec 23, 2015.

FDA first approved this application on Dec 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAMZARIC 14 MG-10 MG CAPSULE

memantine hydrochloride and donepezil hydrochloride
$19.8498per EA

Strength

10; 14 mg/1; mg/1

Manufacturer

Allergan, Inc.

NDC

00456121430

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA206439

FDA Approved

12/23/2014

TE Code

AB

On Market Since

12/24/2014

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors
N-methyl-D-aspartate Receptor Antagonist
NMDA Receptor Antagonists

Price Statistics

The NADAC for NAMZARIC 14 MG-10 MG CAPSULE has been published 557 times since Dec 23, 2015, and over the history we have for it it has risen 92.6%. The table below summarizes its recorded NADAC range and movement.

Current price$19.8498 per EA
All-time high$19.8507 (Aug 12, 2026)
All-time low$10.3076 (Dec 23, 2015)
52-week high$19.8507
52-week low$19.7862
Median price$16.2942
Average price$15.9727
Largest weekly change+9.9% (Jan 13, 2016)
Weeks tracked557
Tracking sinceDec 23, 2015

Price History

1W

-0.0%

1M

-0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.2%

3Y

+10.1%

5Y

+21.8%

All

+92.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 63%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of NAMZARIC 14 MG-10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NAMZARIC 14 MG-10 MG CAPSULE, manufactured by Allergan, Inc., is $19.8498 per EA (NDC 00456121430), effective Aug 19, 2026.

How has the price of NAMZARIC 14 MG-10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for NAMZARIC 14 MG-10 MG CAPSULE has risen 92.6%. It has been tracked across 557 weekly CMS publications since Dec 23, 2015.

What are the highest and lowest recorded NADAC prices for NAMZARIC 14 MG-10 MG CAPSULE?

Since Dec 23, 2015, the NADAC for NAMZARIC 14 MG-10 MG CAPSULE has ranged from a low of $10.3076 (Dec 23, 2015) to a high of $19.8507 (Aug 12, 2026), with a median of $16.2942 per EA.

Are there cheaper alternatives to NAMZARIC 14 MG-10 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEMANTINE-DONEPEZIL ER 14-10 MG, is $7.3348 per EA — about 63% below NAMZARIC 14 MG-10 MG CAPSULE.

Who manufactures NAMZARIC 14 MG-10 MG CAPSULE?

NAMZARIC 14 MG-10 MG CAPSULE (NDC 00456121430) is labeled by Allergan, Inc., and CMS classifies it as a brand product.